MARKET

LIXT

LIXT

Lixte Biotechnology Hldgs Inc
NASDAQ
2.440
-0.230
-8.61%
Closed 16:00 03/06 EST
OPEN
2.540
PREV CLOSE
2.670
HIGH
2.665
LOW
2.420
VOLUME
47.12K
TURNOVER
--
52 WEEK HIGH
6.26
52 WEEK LOW
0.6400
MARKET CAP
13.92M
P/E (TTM)
-2.0750
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LIXT last week (0223-0227)?
Weekly Report · 4d ago
Weekly Report: what happened at LIXT last week (0216-0220)?
Weekly Report · 02/23 09:23
LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary
TipRanks · 02/18 17:00
Lixte Elevates Liora Leadership to Advance Proton Therapy
TipRanks · 02/18 14:00
Lixte Biotechnology appoints Sidney Braun as CEO, Liora
TipRanks · 02/18 13:20
Lixte Subsidiary Liora Technologies Europe Names Sidney Braun CEO
Reuters · 02/18 13:04
LIXTE BIOTECHNOLOGY APPOINTS SIDNEY BRAUN AS CEO OF ITS LIORA TECHNOLOGIES EUROPE LTD. SUBSIDIARY
Reuters · 02/18 13:00
*LIXTE Biotechnology Appoints Sidney Braun as CEO of Its Liora Technologies Europe Subsidiary >LIXT
Dow Jones · 02/18 13:00
More
About LIXT
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The Company’s product pipeline is primarily focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. The Company’s inhibitors of protein phosphatases have significant therapeutic potential for a broad range of cancers. It is focused on the clinical development of a specific protein phosphatase inhibitor, LB-100. In addition, lead compounds of the LB-100 series have anti-cancer activity in animal models of glioblastoma multiforme, neuroblastoma, and medulloblastoma, all cancers of neural tissue. Its subsidiary, Liora Technologies Europe Ltd., offers electronically controlled proton therapy systems for treating tumors in various types of cancers.

Webull offers Lixte Biotechnology Holdings Inc stock information, including NASDAQ: LIXT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIXT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LIXT stock methods without spending real money on the virtual paper trading platform.